Welcome to BioAsia

Participating in Global Bio-Manufacturing Competition
Building a Benchmark Enterprise in the Bio-Economy Era

Leveraging microorganisms (especially entomopathogenic fungal resources) as the foundation and synthetic biology as its core. We conduct systematic research and industrial transformation across the entire value chain and in all dimensions. We have been awarded the "China Patent Gold Award" and has received approvals for "National Novel Food Ingredient," "New Plant Variety Right," among other accolades.

Welcome to BioAsia

Participate in the Global Biomanufacturing Industry Competition
Build a Benchmark Enterprise in the Bioeconomy Era

Using microorganisms, especially entomogenous fungal resources, as the chassis, and synthetic biology technology as the core, we conduct systematic research and industrial transformation across the entire chain and all dimensions. The company has won multiple awards, including the China Patent Gold Award, national new food ingredient approval, and national new variety protection.

Business Portfolio

Four Core Divisions

Food & Dietary Supplements

Rooted in quality and driven by innovation, we have built robust technological and industrial capabilities in the food and dietary supplements sector. Guided by the traditional wisdom of "food as medicine and medicine as food," we integrate cutting-edge technologies to advance from theoretical research and technological breakthroughs to commercialization, with coordinated progress across all fronts.

Biomaterials & Bio-Manufacturing

We integrate synthetic biology, fermentation engineering, material science and digital technologies to build a full-chain innovation platform covering R&D to industrialization, delivering leading technical solutions for the global biomanufacturing industry and empowering a greener future.

Bio-Agriculture

Extending the agricultural value chain and advancing deep processing of agricultural products, we are building a comprehensive, green industrial system from farm to table. Driven by innovation and committed to uncompromising quality, BioAsia continues to deepen its roots in the agricultural sector, contributing its strength to the modernization of agriculture.

Science & Science Communication

Blending cutting-edge research with nature exploration, we demonstrate the boundless charm of biotechnology. Here at the intersection of science and public education, we offer both in-depth technological inquiry and rich cultural exhibitions — inspiring minds and connecting to the future.

BioAsia

BioAsia Biotech CO., LTD (referred to as "BioAsia") was founded through the initiative of the Shanghai BioAsia Group and was restructured and established in 2010. BioAsia leverages microbial resources (with a particular focus on entomopathogenic fungi) as its foundation and synthetic biology as its core driver. BioAsia is dedicated to the multi-dimensional application of entomopathogenic fungi, conducting systematic research, industrial transformation, and international expansion across the entire value chain and in all dimensions.

Our R&D and industrial bases are located in Pinghu, Zhejiang (Headquarters), Huai'an, Jiangsu, Shanghai, and Eskilstuna, Sweden. The Group's subsidiaries include Zhejiang BioAsia Health Food Co., Ltd., Shanghai BioAsia Bio-Engineering Technology Co., Ltd., Jiangsu BioAsia CordyFarm, Plantamed AB (a Swedish botanical pharmaceuticals company), the Zhejiang BioAsia Life Science Research Institute, the Cordyseum, and the Microbe Science Museum. BioAsia owns an advanced microbial strain bank and a solid-state biotech fermentation center, forging outstanding quality through technological innovation and guarding human health with a spirit of craftsmanship.

China Patent Gold Award

57+

Intellectual Property Patents

50+

Scientists & R&D Team

Global R&D & Industrial Bases

Our Team

Scientific Team

Zhou Honghao

Academician of the Chinese Academy of Engineering

World-renowned genetic pharmacologist, pioneer and leader of genetic pharmacology in China, and founder of personalized medicine

He has long been engaged in the teaching, research and industrialization of genetic pharmacology and pharmacogenomics. He discovered and illustrated multiple phenomena, mechanisms and laws of ethnic and individual drug differences caused by genetic factors, and established a genetic pharmacology theoretical system with Chinese national characteristics. He has published more than 300 papers in international SCI journals including the New England Journal of Medicine.

Learn More →

Zhou Honghao